CompletedNCT00080158
Three treatment approaches for teens with depression after a suicide attempt
About this title
Read the official source — NCT00080158Medication studyAges 12–18United States
Understand this study
Who was this study for?
Listed age limits: 12 years to 18 years.
- Listed locations
- Baltimore and 5 more locationsSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateMarch 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 120
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 12 Years to 18 Years
- Official registry ID
- NCT00080158
- Official title
Show the full official title
Treatment of Adolescent Suicide Attempters (TASA)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Baltimore · New York · Durham
2 more locations
- Pittsburgh
- Dallas
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including fluoxetine, sertraline, citalopram, escitalopram, bupropion, mirtazapine, venlafaxine and lithium.
Who was this study for?
Listed age limits: 12 years to 18 years.
